Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016, Article ID 3879406, 4 pages
http://dx.doi.org/10.1155/2016/3879406
Case Report

A Rare Complication of Trimethoprim-Sulfamethoxazole: Drug Induced Aseptic Meningitis

1Section of Hospital Medicine, Division of General Internal Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
2Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
3Children’s Hospital of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
4Section of Perioperative Medicine and Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA

Received 28 May 2016; Accepted 10 July 2016

Academic Editor: Pere Domingo

Copyright © 2016 Pinky Jha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Smilack, “Trimethoprim-sulfamethoxazole,” Mayo Clinic Proceedings, vol. 74, no. 7, pp. 730–734, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. River, L. Averbuch-Heller, M. Weinberger et al., “Antibiotic induced meningitis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 57, no. 6, pp. 705–708, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. H. L. Widener and B. H. Littman, “Ibuprofen-induced meningitis in systemic lupus erythematosus,” Journal of the American Medical Association, vol. 239, no. 11, pp. 1062–1064, 1978. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Kremer, R. Ritz, and F. Brunner, “Aseptic meningitis as an adverse effect of cotrimoxazole,” The New England Journal of Medicine, vol. 308, no. 24, p. 1481, 1983. View at Google Scholar · View at Scopus
  5. G. Morís and J. C. Garcia-Monco, “The challenge of drug-induced aseptic meningitis revisited,” The Journal of the American Medical Association, vol. 174, no. 9, pp. 1511–1512, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Jurado, S. L. Carpenter, and D. Rimland, “Trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection,” The American Journal of the Medical Sciences, vol. 312, no. 1, pp. 27–29, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Frank-Briggs and O. Oluwatade, “Drug induced aseptic meningitis: a diagnostic challenge,” Nigerian Journal of Paediatrics, vol. 41, no. 2, pp. 138–140, 2014. View at Publisher · View at Google Scholar
  8. K. E. Bruner, C. A. Coop, and K. M. White, “Trimethoprim-sulfamethoxazole-induced aseptic meningitis—not just another sulfa allergy,” Annals of Allergy, Asthma and Immunology, vol. 113, no. 5, pp. 520–526, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. J. Connolly and S. M. Hammer, “The acute aseptic meningitis syndrome,” Infectious Disease Clinics of North America, vol. 4, no. 4, pp. 599–622, 1990. View at Google Scholar · View at Scopus
  10. J. Antonen, J. Hulkkonen, A. Pasternack, and M. Hurme, “Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling aseptic meningitis,” Archives of Internal Medicine, vol. 160, no. 13, pp. 2066–2067, 2000. View at Google Scholar · View at Scopus
  11. W. Saliba, M. Assi, and Wichita, “TMP-SMX induced aseptic meningitis,” Kansas Journal of Medicine, 2008. View at Google Scholar